close

Fundraisings and IPOs

1 45 46 47 48 49 74
Number of results: 1471
Date Company Amount Funding type Investors Therapeutic area Type of Information
2014-01-13 Galapagos (Belgium) € 2.9 million grant Flemish Agency for Innovation by Science and Technology (IWT) (Belgium) Rare diseases - Genetic diseases Grant
2014-01-10 Atara Biotherapeutics (USA - CA) $52 million series B financing round Amgen Ventures (USA - CA) Celgene (USA - NJ) EcoR1 Capital (USA - CA) Alexandria Venture Investments (USA - CA) DAG Ventures (USA - CA) Domain Associates (USA - CA) Kleiner Perkins Caufield & Byers (USA - CA) The Baupost Group (USA - MA) Cancer - Oncology - Kidney diseases - Renal diseases Series B financing round
2014-01-09 AC Immune (Switzerland) CHF 20 million (€16.1 million) series D financing round Neurodegenerative diseases Series D financing round
2014-01-08 Apitope (UK) and Grave's consortium (GSK Vaccines, Quintiles and KWS Biotest) € 6 million grant European Commission’s Seventh Framework Program (FP7) Allergic diseases - Immunological diseases Grant
2014-01-08 eoStrep, a consortium consisting of Lund University (Sweden), MinervaX (Denmark), CiToxLAB A/S (Denmark), and BioKinetic Europe Ltd. (UK) € 6 million grant European Commission’s Seventh Framework Program (FP7) Infectious diseases Grant
2014-01-08 MinervaX (Denmark) DKK 22 million (€ 3 million) Infectious diseases Fundraising
2014-01-07 Isarna Therapeutics (Germany) € 13 Million fundraising AT NewTec (Germany), MIG-managed funds (Germany) Cancer - Oncology Fundraising
2014-01-06 Scancell Holdings (UK) £80,000 (€ 96,318) grant Nottingham City Council (UK) Cancer - Oncology Grant
2013-12-30 TopiVert (UK) fundraising Imperial Innovations (UK) Gastrointestinal diseases - Digestive diseases - Inflammatory diseases - Ophtalmological diseases Fundraising
2013-12-24 Oramed Pharmaceuticals (Israel) $15.8 million private placement Metabolic diseases Private placement
2013-12-23 Tigenix (Belgium) € 10 million loan Kreos Capital (UK) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases Loan
2013-12-19 Epigenomics (Germany - USA) € 2.5 million private placement Diagnostic - Cancer - Oncology Private placement
2013-12-17 Crescendo Biologics (UK) £17.5 million (€20.7 million) series A financing round Innovations (UK), Astellas Venture Management (Japan), Sofinnova Partners (France) Cancer - Oncology - Inflammatory diseases Series A financing round
2013-12-17 BIO-INSPIRE consortium (Fujifilm (The Netherlands) ISTEC (Italy), Erasmus Medical Center (The Netherlands), Medicyte (Germany), Fraunhofer Institute (Germany), Bone Therapeutics (Belgium) and Universita di Bologna (Italy) €3.8 million Marie Curie grant European Commission’s Seventh Framework Program (FP7) Bone diseases - Regenerative medicine Grant
2013-12-17 Atara Biotherapeutics (USA - CA) $38.5 million series B financing round Amgen Ventures (USA - CA) Celgene (USA - NJ) EcoR1 Capital (USA - CA) Alexandria Venture Investments (USA - CA) DAG Ventures (USA - CA) Domain Associates (USA - CA) Kleiner Perkins Caufield & Byers Cancer - Oncology - Kidney diseases - Renal diseases Series B financing round
2013-12-16 Neovacs (France) equity line Allergic diseases - Immunological diseases Credit line
2013-12-11 BrainStorm Cell Therapeutics (USA - Israel) $800,000 (€ 582,114) grant Office of the Chief Scientist (OCS -Israel) Neurodegenerative diseases Grant
2013-12-11 Ario Pharma (UK) £1.9 million (€ 2.27 million) fundraising New Science Ventures, Forbion Capital Partners and Seroba Kernel Life Sciences. Respiratory diseases - Inflammatory diseases Fundraising
2013-12-09 Gecko Biomedical (France) €8 million series A financing round Omnes Capital (France) CM-CIC Capital Finance (France) CapDecisif Management (France) Medical devices Series A financing round
2013-12-04 AMCARE (Advanced Materials for CArdiac REgeneration) consortium (AdjuCor (Germany), Cardio3Biosciences (Belgium), Contipro (Czech Republic), Explora BioTech (Italy), Innova (Italy), Trinity College Dublin (Ireland), the Fraunhofer Institute for Interfacial Engineering and Biotechnology (Germany), the Eberhard Karls Universitat Tübingen (Germany) Boston Scientific based in Galway, Ireland) €8.7 million grant European Commission’s Seventh Framework Program (FP7) Cardiovascular diseases Grant